Jennifer Zachary - Jun 3, 2022 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Stock symbol
RGNX
Transactions as of
Jun 3, 2022
Transactions value $
$0
Form type
4
Date filed
6/7/2022, 04:26 PM
Previous filing
May 5, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +6.02K $0.00 6.02K Jun 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Option (Right to Buy) Award $0 +29.7K $0.00 29.7K Jun 3, 2022 Common Stock 29.7K $22.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). One-third of the shares subject to this RSU will vest on each of June 1, 2023, June 1, 2024 and June 1, 2025 while the recipient provides continuous service to the Issuer.
F2 The option will vest in equal monthly installments over the 36 months following June 3, 2022 while the optionee provides continuous service to the Issuer.